CORONA, Calif., March 5 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals,
Inc. (NYSE: WPI) announced today that the Company will be making a
presentation at the Raymond James 23rd Annual Institutional Investors
Conference on Wednesday, March 6, 2002 at 8:40 a.m. EST (5:40 a.m. PST).
Michael Boxer, Watson's Chief Financial Officer, will provide an overview of
the Company's business.
(Photo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )
A live audio webcast of the presentation may be accessed at the following
URL: http://customer.nvglb.com/RaymondJames/Institutional/ . Listeners
should go to this site at least 15 minutes prior to the event to register for
this event. A replay of the presentation will be available for 90 days from
the presentation date by accessing the same URL.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a
leading specialty pharmaceutical company that develops, manufactures, markets
and distributes branded and generic pharmaceutical products. Watson pursues a
growth strategy combining internal product development, strategic alliances
and collaborations and synergistic acquisitions of products and businesses.
This and past press releases of Watson Pharmaceuticals, Inc. are available
at Watson's web site at http://www.watsonpharm.com . In addition, press releases are
available through PR Newswire's website at http://www.prnewswire.com .
SOURCE Watson Pharmaceuticals, Inc.
 back to top
Related links:
http://www.watsonpharm.com
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
Audio:http://customer.nvglb.com/RaymondJames/Institutional
CONTACT:
Patty Eisenhaur, Director, Investor Relations
of Watson Pharmaceuticals, Inc., +1-909-493-5611
|
